Skip to main content

Petmed Express Inc(PETS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low2.34
Day High2.46
Open:2.46
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

Top Stories: Petmed Express Inc

Select a category then submit the form to load news
PetMed Express Shareholders Approve Directors, Pay and Auditor
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
PetMeds Extends Existing Shareholder Rights Plan
PetMed Express Faces Nasdaq Compliance Notice
PetMed Express Delays Quarterly Report Filing
Petmed Express Appoints Interim CEO and President
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
PetMeds® Files Form 10-K for Fiscal 2025
Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
PetMed Express Announces $1.2 Million Trade Name Impairment
PetMed Express Approves Salary for Interim CEO
PetMed Express Faces Nasdaq Compliance Deadline
PetMed Express Announces CEO and CFO Resignations
PetMed Express Delays Quarterly Report Filing
PetMed Express, Inc. Announces Management Changes
Morgan Stanley Reaffirms Their Sell Rating on Petmed Express (PETS)
PetMed Express Board Restructures After Director Resignation
PetMeds Partners with myBalto Foundation to Raise Nearly $45,000 to Alleviate Financial Stress Pet Owners Face with Emergency Vet Bills
PetMed Express Faces Nasdaq Filing Compliance Notice
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
PetMed Express Delays Annual Report Amid Investigations
PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing
Options Volatility and Implied Earnings Moves This Week, June 16 – June 20, 2025
Options Volatility and Implied Earnings Moves Today, June 16, 2025
PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25
Options Volatility and Implied Earnings Moves Today, June 10, 2025
Options Volatility and Implied Earnings Moves This Week, June 09 – June 12, 2025
PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
Morgan Stanley Sticks to Their Sell Rating for Petmed Express (PETS)
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors

Profile

PetMed Express, Inc. and subsidiaries, d/b/a 1-800-PetMeds (the `Company`), is a leading nationwide pet pharmacy. The Company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The Company offers consumers an attractive alternative for obtaining pet medications in terms of convenience, price, and speed of delivery. The Company markets its products through national advertising campaigns, which aim to increase the recognition of the `1-800-PetMeds` brand name, and `PetMeds` family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers, and maximize repeat purchases. The majority of the Company's sales are to residents in the United States. The Company's corporate headquarters and distribution facility are located in Delray Beach, Florida.